Brief: CanSino Sued By Belcher Farmaceutica Over COVID Vaccine Cooperation Dispute
March 13 (Reuters) - CanSino Biologics 688185.SS :
* SAYS BELCHER FARMACEUTICA LTDA FILED A LAWSUIT AGAINST CO
OVER
COVID-19 VACCINE-RELATED COOPERATION DISPUTE
* SAYS BELCHER ASKED COURT TO ORDER CO TO PAY ABOUT 241
MILLION
YUAN OF LOST EARNINGS AND MORAL DAMAGES
* SAYS IT HAS A STRONG DEFENCE POSITION, EXPECTS THE
LITIGATION TO
HAVE NO SIGNIFICANT IMPACT ON CO'S PRODUCTION AND OPERATION
Source text
Further company coverage: 688185.SS
(Reporting by Beijing newsroom)
((Ella.Cao@thomsonreuters.com;))
Recent news on Cansino Biologics
See all newsBrief: CanSino Biologics Says China's NMPA Granted Priority Review Status To NDA For TD5CP Adolescent, Adult
Brief: CanSino Biologics Reports Widened Net Loss For Q1
Brief: CanSino Biologics Says 2025 Net Profit At 27.9 Million Yuan
Brief: CanSino Biologics Prelim 2025 Net Profit At 27.9 Million Yuan
Brief: CanSino Biologics Expects To Have Returned to Net Profit In 2025